scPharmaceuticals Inc. - SCPH Operating Margin

scpharmaceuticals.com - graphic logo of issuer SCPH

scPharmaceuticals Inc. (SCPH) develops innovative subcutaneous systems for heart failure therapy, attracting specialists through its scientific culture and stock options. The operating profit margin reflects efficiency dynamics, while the -133.20 metric confirms the current level. The company is actively hiring cardiologists for expansion while maintaining a stable engineering team. The outpatient treatment format reduces insurer costs and minimizes medical risks.

scPharma (SCPH): Operating Profit Rate from 07/04/2022 to 10/18/2025

Analytical breakdowns and data insights for company scPharmaceuticals, Inc. (SCPH)

- share price and consensus valuation forecast:
Comprehensive company analysis:scPharmaceuticals Inc., SCPH
Finished products of scPharmaceuticals

For scPharmaceuticals Inc. (SCPH), operating margin trends reflect the efficiency of core business process management. This metric measures the share of operating profit in total revenue before financial expenses and taxes. It is calculated by dividing the operating result by the company's total income. Growth in this metric confirms the success of diversification through the implementation of home treatment systems for heart failure. Positive momentum here signals model scalability and a reduction in patent risks.

Competitors of scPharmaceuticals Inc.

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.